Immediate action is needed to transform the nation’s drug pricing system in ways that will lower prices, strengthen Medicare, and promote the well-being of those who rely on its coverage. H.R. 3 would significantly advance these goals, in part by authorizing Medicare to negotiate prices for certain drugs; imposing inflationary rebates; and restructuring Part D to cap beneficiary out-of-pocket costs at $2,000 per year, reduce the federal government’s liability, and better align pricing incentives.
Read More
Testimony of Frederic Riccardi, President Medicare Rights Center, on “The Future of Telehealth: How COVID-19 is Changing the Delivery of Virtual Care” for the United States House of Representatives Committee on Energy & Commerce Subcommittee on Health.
Read More
As policymakers consider the post-pandemic Medicare telehealth landscape, the Medicare Rights Center and the Center for Medicare Advocacy offer our shared perspective on next steps. In these joint principles, we urge a cautious, thoughtful, and evidence-based approach that centers the unique and evolving needs of people with Medicare.
Read More
Introduction Chairwoman Eshoo, Dr. Burgess, and members of the House Committee on Energy & Commerce, Subcommittee on Health: I am Fred Riccardi, president of the Medicare Rights Center (Medicare Rights). Medicare Rights is a national, non-profit organization that works to ensure access to affordable health care for older adults and […]
Read More
Chairman Grassley, Ranking Member Wyden, and distinguished Members of the Senate Committee on Finance, on behalf of the Medicare Rights Center (Medicare Rights), thank you for your bipartisan efforts to address the problem of high and rising prescription drug prices, and for the opportunity to share our perspective on this […]
Read More
The undersigned organizations of the Observation Stays Coalition have come together to address a surprise medical billing issue that affects Medicare patients in hospitals who are called observation status patients or outpatients, although the medically necessary care they need and receive is no different from the medically necessary care provided […]
Read More
The undersigned organizations of the Observation Stays Coalition have come together to address a surprise medical billing issue that affects Medicare patients in hospitals who are called observation status patients or outpatients, although the medically necessary care they need and receive is no different from the medically necessary care provided […]
Read More
The undersigned organizations of the Observation Stays Coalition have come together to address a surprise medical billing issue that affects Medicare patients in hospitals who are called observation status patients or outpatients, although the medically necessary care they need and receive is no different from the medically necessary care provided […]
Read More
Medicare Rights Center President Joe Baker testimony in support of the Centers for Medicare & Medicaid Services (CMS) proposal to test new ways to pay for prescription drugs covered under Medicare Part B, at a hearing held by the Subcommittee on Health of the U.S. House Committee on Energy and […]
Read More
Joe Baker, President of the Medicare Rights Center, testified before the U.S. House Committee on Ways & Means, Subcommittee on Health about the future of the Medicare Advantage (MA) program, the positive impact of the Affordable Care Act (ACA) on MA, and how to further improve MA plans for people […]
Read More
